MedTech Europe’s Bisazza: How Expert Panel Delays Have Caused Uncertainty For Companies
Executive Summary
Medtech manufacturers are substantially ready to demonstrate compliance with the EU MDR for new high-risk devices, but the system for checking notified body reviews of their clinical work is causing hold-ups for some highly innovative products, MedTech Europe’s Oliver Bisazza told Medtech Insight in a recent interview.
You may also be interested in...
Removing EU’s Innovative Device Blockage: Expert Panels Due By End Of July After Lengthy Delays
The speed to market for innovative products in the EU has been hampered because of the time it has taken to set up “expert panels” under the Medical Device Regulation. Will these products now make 26 May 2021 deadline?
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.